Market Tracker

02/20 5:35am ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

9.88
Delayed Data
As of Feb 17
 +0.07 / +0.71%
Today’s Change
9.05
Today|||52-Week Range
16.54
-5.54%
Year-to-Date

Today’s Trading

Previous close9.81
Today’s open9.66
Day’s range9.65 - 9.90
Volume71,246
Average volume (3 months)61,483
Market cap$168.5M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-60.54%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-99.96%
P/E ratio--
Price/Sales47,981.20
Price/Book2.09

Competitors

 Today’s
change
Today’s
% change
NYMXNymox Pharmaceutical...0.000.00%
CEMPCempra Inc+0.18+5.51%
STMLStemline Therapeutic...+0.40+6.25%
OPHTOphthotech Corp-0.14-3.02%
Data as of 3:59pm ET, 02/17/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$3.0K
Annual profit (last year)-$21.1M
Net profit margin-703,000.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts